Residual disease after primary surgical treatment for advanced epithelial ovarian cancer; Part 2: Network meta-analysis incorporating expert elicitation to adjust for publication bias : American Journal of Therapeutics

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Therapeutic Advance

Residual disease after primary surgical treatment for advanced epithelial ovarian cancer; Part 2: Network meta-analysis incorporating expert elicitation to adjust for publication bias

Bryant, Andrew1,*; Grayling, Michael1; Elattar, Ahmed2; Gajjar, Ketankumar3; Craig, Dawn1; Vale, Luke1; Naik, Raj4

Author Information
American Journal of Therapeutics: November 1, 2022 - Volume - Issue - 10.1097/MJT.0000000000001548
doi: 10.1097/MJT.0000000000001548
  • Buy
  • SDC
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.